Product NDC: | 0168-0216 |
Proprietary Name: | Erythromycin |
Non Proprietary Name: | erythromycin |
Active Ingredient(s): | 20 mg/g & nbsp; erythromycin |
Administration Route(s): | TOPICAL |
Dosage Form(s): | GEL |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0168-0216 |
Labeler Name: | E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA064184 |
Marketing Category: | ANDA |
Start Marketing Date: | 19970930 |
Package NDC: | 0168-0216-30 |
Package Description: | 30 g in 1 TUBE (0168-0216-30) |
NDC Code | 0168-0216-30 |
Proprietary Name | Erythromycin |
Package Description | 30 g in 1 TUBE (0168-0216-30) |
Product NDC | 0168-0216 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | erythromycin |
Dosage Form Name | GEL |
Route Name | TOPICAL |
Start Marketing Date | 19970930 |
Marketing Category Name | ANDA |
Labeler Name | E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc. |
Substance Name | ERYTHROMYCIN |
Strength Number | 20 |
Strength Unit | mg/g |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |